Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis

NCT00938015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 303

Last updated 2013-05-27

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate if the data obtained in controlled clinical trials are confirmed when Enbrel is used in usual clinical practice in Belgium according to local reimbursement criteria.

Conditions

  • Arthritis, Psoriatic

Interventions

OTHER

Questionnaire

This is a non-interventional study

OTHER

Questionnaire

This is a non-interventional study

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00938015 on ClinicalTrials.gov